Insights

Growing Pandemic Response MaximBio has recently secured a significant $49.5 million manufacturing award from the U.S. Department of Health and Human Services to enhance pandemic testing capabilities, indicating a strong government focus on rapid diagnostic solutions and potential expansion opportunities in public health sectors.

Leadership Expansion The appointment of a new CEO, Jonathan Maa, suggests strategic growth and a focus on strengthening market presence, offering opportunities to align sales initiatives with future leadership-driven initiatives and innovations.

Innovation in Rapid Testing MaximBio's development of COVID-19 antigen tests and rapid point-of-care diagnostics positions the company as a key player in the rapid test market, creating opportunities to collaborate on emerging infectious disease testing and expand product distribution channels.

Manufacturing Momentum With high-volume capacity supporting over 15 million devices per month and flexible production capabilities, MaximBio offers scalable manufacturing partnerships ideal for large-scale diagnostic rollouts and regional distribution agreements.

Regulatory & Quality Edge The company's compliance with FDA cGMP and ISO standards, coupled with a proven track record in government programs, provides a compelling value proposition for health agencies and diagnostics developers seeking reliable, compliant manufacturing partners.

Similar companies to Maxim Biomedical, Inc.

Maxim Biomedical, Inc. Tech Stack

Maxim Biomedical, Inc. uses 8 technology products and services including RSS, Microsoft 365, Font Awesome, and more. Explore Maxim Biomedical, Inc.'s tech stack below.

  • RSS
    Content Management System
  • Microsoft 365
    Email
  • Font Awesome
    Font Scripts
  • jQuery
    Javascript Libraries
  • Google Maps
    Maps
  • Webflow
    Page Builders
  • reCAPTCHA
    Security
  • X-Content-Type-Options
    Web & Portal Technology

Media & News

Maxim Biomedical, Inc.'s Email Address Formats

Maxim Biomedical, Inc. uses at least 2 format(s):
Maxim Biomedical, Inc. Email FormatsExamplePercentage
First.Last@mbidiagnostic.comJohn.Doe@mbidiagnostic.com
50%
First_Last@mbidiagnostic.comJohn_Doe@mbidiagnostic.com
38%
FirLast@mbidiagnostic.comJohDoe@mbidiagnostic.com
12%
First@maximbio.comJohn@maximbio.com
50%
First.Last@maximbio.comJohn.Doe@maximbio.com
50%

Frequently Asked Questions

Where is Maxim Biomedical, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Maxim Biomedical, Inc.'s main headquarters is located at 1500 East Gude Drive Suite a Rockville, Maryland 20850 United States. The company has employees across 1 continents, including North America.

What is Maxim Biomedical, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Maxim Biomedical, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Maxim Biomedical, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Maxim Biomedical, Inc.'s official website is maximbio.com and has social profiles on LinkedInCrunchbase.

How much revenue does Maxim Biomedical, Inc. generate?

Minus sign iconPlus sign icon
As of March 2026, Maxim Biomedical, Inc.'s annual revenue is estimated to be $3.8M.

What is Maxim Biomedical, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Maxim Biomedical, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Maxim Biomedical, Inc. have currently?

Minus sign iconPlus sign icon
As of March 2026, Maxim Biomedical, Inc. has approximately 15 employees across 1 continents, including North America. Key team members include Chief Quality Officer: J. M.Chief Scientific Officer: J. M.Chief Financial Officer: T. M.. Explore Maxim Biomedical, Inc.'s employee directory with LeadIQ.

What industry does Maxim Biomedical, Inc. belong to?

Minus sign iconPlus sign icon
Maxim Biomedical, Inc. operates in the Biotechnology Research industry.

What technology does Maxim Biomedical, Inc. use?

Minus sign iconPlus sign icon
Maxim Biomedical, Inc.'s tech stack includes RSSMicrosoft 365Font AwesomejQueryGoogle MapsWebflowreCAPTCHAX-Content-Type-Options.

What is Maxim Biomedical, Inc.'s email format?

Minus sign iconPlus sign icon
Maxim Biomedical, Inc.'s email format typically follows the pattern of First.Last@mbidiagnostic.com. Find more Maxim Biomedical, Inc. email formats with LeadIQ.

When was Maxim Biomedical, Inc. founded?

Minus sign iconPlus sign icon
Maxim Biomedical, Inc. was founded in 2005.

Maxim Biomedical, Inc.

Biotechnology ResearchMaryland, United States11-50 Employees

At MaximBio, we partner with diagnostics and life science organizations to develop, analytically validate, and manufacture scalable immunoassays, LFAs, and ELISA platforms designed for regulatory and commercial success. With 20+ years of experience in immunoassay development and manufacturing, we deliver end-to-end support across lateral flow, ELISA, and custom diagnostic platforms - from early feasibility through full-scale production.

Our approach is built around designing for manufacturability and regulatory readiness from day one, reducing downstream risk and accelerating time to market for both emerging innovators and established diagnostics leaders.

Innovation & Technical Expertise
• Advanced chemistry and reagent design across lateral flow and ELISA platforms
• Rapid feasibility, prototyping, and verification workflows
• Assay development aligned to scale-up, transfer, and commercialization requirements

Quality & Compliance
• FDA cGMP registered for medical device manufacture and distribution
• Compliant with 21 CFR Part 820
• ISO 13485:2016 certified for manufacturing and packaging of medical devices
• Proven track record: >99.99% acceptance rate for tests developed and manufactured under U.S. government COVID response programs

Scalable, Flexible Manufacturing in the United States
MaximBio combines high-volume capacity - 15+ million devices per month - with the flexibility to support small-batch prototyping, validation builds, and clinical production. Our vertically integrated, U.S.-based infrastructure enables strong supply chain control, rapid iteration, and dependable commercial execution.

Our Commitment
We operate as a long-term development and manufacturing partner, focused on technical rigor, regulatory alignment, and operational excellence. When product performance, quality, and delivery timelines matter, MaximBio provides the structure, scale, and scientific depth to move programs forward with confidence.

Section iconCompany Overview

Headquarters
1500 East Gude Drive Suite a Rockville, Maryland 20850 United States
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2005
Employees
11-50

Section iconFunding & Financials

  • $1M$10M

    Maxim Biomedical, Inc.'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Maxim Biomedical, Inc.'s revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.